UK markets closed

Establishment Labs Holdings Inc. (ESTA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
52.83+3.33 (+6.73%)
At close: 04:00PM EDT
53.00 +0.17 (+0.32%)
After hours: 06:31PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close49.50
Open50.80
Bid52.68 x 100
Ask52.86 x 100
Day's range50.69 - 52.83
52-week range16.96 - 73.00
Volume251,907
Avg. volume363,195
Market cap1.451B
Beta (5Y monthly)1.25
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Establishment Labs Notes Presentation of 4-Year Results from Motiva U.S. IDE Study at The Aesthetic Meeting 2024

    NEW YORK, May 02, 2024--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, noted the presentation today of an update on the Motiva US IDE Study. The update will include four-year patient follow-up data for primary augmentation subjects. The Medical Director of the Study, Dr. Caroline Glicksman, who is also an Investigator in the Study, will present the result

  • Business Wire

    Establishment Labs Announces Appointment of Jeff Ehrhardt as General Manager of North America

    NEW YORK, May 01, 2024--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced today that Jeff Ehrhardt has joined the company as General Manager of North America. After having spent over 25 years at Allergan Aesthetics, an Abbvie Company, Mr. Ehrhardt joins Establishment Labs with responsibilities including the anticipated launch of Motiva implants in

  • Business Wire

    Establishment Labs to Announce First Quarter 2024 Financial Results on May 8

    NEW YORK, April 24, 2024--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended March 31, 2024 after the market closes on Wednesday, May 8, 2024, and will host a conference call at 4:30 pm ET that day to discuss those results.